MHRA Drug Safety Update

MHRA Drug Safety Update

January 9, 2018

Date issued: 9th January 2018

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 11, Issue 6, January 2018) has been published and includes articles on:

  • daclizumab (Zinbryta▼) and risk of severe liver injury: new restrictions to use and strengthened liver monitoring;
  • drug-name confusion: reminder to be vigilant for potential errors;
  • co-dydramol: prescribe and dispense by strength to minimise risk of medication error; and
  • herbal medicines: report suspected adverse reactions via the Yellow Card Scheme.

To see the latest MHRA Drug Safety Update in full, visit the website.

Posted in:

More Latest News >

October 2018 Category M prices

Category M reimbursement prices for October 2018 can be found here. These show a net overall reduction compared to July 2018...

PSNC CEO webinar now on-demand

Community pharmacy contractors can now access an online recording of PSNC’s recent CEO webinar. Almost 500 people registered for yesterday’s...

Ask PSNC: Flu FAQs

The team at PSNC has received a number of queries on the NHS Flu Vaccination Service 2018/19. Below are some...